
    
      Study NI-0501-10 is an open-label, single arm, multicenter, Phase 2/3 interventional study.

      The study enrolls adult patients with hemophagocytic lymphohistiocytosis (HLH), specifically
      newly diagnosed patients with malignancy-associated HLH (M-HLH), and newly diagnosed or
      previously treated patients with non-malignancy-associated HLH.
    
  